Three-Dimensional Organoids in Oral Cancer Research: A Paradigm Shift in Oncology
Academia Journal of Medicine · 16.04.2026 · 9 (1) · 157-160
DOI: 10.48165/ajm.2026.9.01.32 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academia Journal of Medicine, online erschienen am 16.04.2026. Verfasst von Prachi Hazari und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Oral cancer, predominantly oral squamous cell carcinoma (OSCC), remains a major global health burden with high morbidity and mortality rates. Traditional two-dimensional (2D) cell cultures and animal models often fail to accurately replicate tumor heterogeneity and the complex tumor microenvironment. Organoids, three-dimensional (3D) in vitro culture systems derived from stem cells or tumor tissues, have emerged as a revolutionary tool in cancer research. Oral cancer organoids closely mimic the histological architecture, genetic profile, and functional characteristics of the original tumor. This review discusses the concept, development, methodologies, and applications of organoids in oral cancer research, highlighting their role in disease modeling, drug screening, and personalized medicine. Additionally, limitations, challenges, and future prospects are addressed.
Zitieren
APA
Hazari, P., Byrappa, B., Sagar, S., Patil, K., & Kalekar, A. (2026). Three-Dimensional Organoids in Oral Cancer Research: A Paradigm Shift in Oncology. Academia Journal of Medicine, 9(1), 157-160. https://doi.org/10.48165/ajm.2026.9.01.32
Vancouver
Hazari P, Byrappa B, Sagar S, Patil K, Kalekar A. Three-Dimensional Organoids in Oral Cancer Research: A Paradigm Shift in Oncology. Academia Journal of Medicine. 2026;9(1):157-160. doi:10.48165/ajm.2026.9.01.32
BibTeX
@article{Hazari2026,
author = {Hazari, Prachi and Byrappa, Brijesh and Sagar, Sai and Patil, Kishor and Kalekar, Anviti},
title = {Three-Dimensional Organoids in Oral Cancer Research: A Paradigm Shift in Oncology},
journal = {Academia Journal of Medicine},
year = {2026},
volume = {9},
number = {1},
pages = {157--160},
doi = {10.48165/ajm.2026.9.01.32}
}
EUVIMED